Privia Health Group, Inc. (NASDAQ:PRVA) Receives $28.00 Consensus PT from Analysts

Key Points

• Privia Health Group, Inc. has received a consensus recommendation of "Buy" from twelve brokerages, with an average price target of $28.00.
• In its latest quarterly earnings report, Privia missed analysts' EPS estimates, reporting $0.02 compared to the expected $0.05, even though revenue grew significantly to $521.15 million.
• Institutional investors hold a significant majority of the company's stock, with 94.48% ownership, indicating strong institutional confidence in Privia Health Group's potential.

Shares of Privia Health Group, Inc. (NASDAQ:PRVA - Get Free Report) have been given an average recommendation of "Moderate Buy" by the thirteen research firms that are covering the firm, MarketBeat reports. Two investment analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has issued a strong buy rating on the company. The average 12 month target price among analysts that have covered the stock in the last year is $28.00.

Several equities research analysts recently issued reports on PRVA shares. Evercore ISI decreased their price target on Privia Health Group from $30.00 to $28.00 and set an "outperform" rating for the company in a report on Wednesday, July 9th. Piper Sandler decreased their price target on Privia Health Group from $36.00 to $35.00 and set an "overweight" rating for the company in a report on Monday, August 11th. JMP Securities reiterated a "market outperform" rating and set a $29.00 price target on shares of Privia Health Group in a report on Monday, April 28th. JPMorgan Chase & Co. upped their price target on Privia Health Group from $29.00 to $32.00 and gave the stock an "overweight" rating in a report on Wednesday, May 28th. Finally, Zacks Research upgraded Privia Health Group from a "strong sell" rating to a "hold" rating in a report on Tuesday, August 19th.

Privia Health Group Stock Performance

Shares of NASDAQ PRVA traded down $0.01 during midday trading on Thursday, hitting $21.39. 480,415 shares of the stock traded hands, compared to its average volume of 1,009,885. The company has a market cap of $2.63 billion, a PE ratio of 194.47, a P/E/G ratio of 3.10 and a beta of 0.80. Privia Health Group has a one year low of $16.47 and a one year high of $26.09. The business has a 50 day moving average price of $20.89 and a two-hundred day moving average price of $22.68.

Privia Health Group (NASDAQ:PRVA - Get Free Report) last released its quarterly earnings data on Thursday, August 7th. The company reported $0.02 EPS for the quarter, missing the consensus estimate of $0.05 by ($0.03). The firm had revenue of $521.15 million for the quarter, compared to the consensus estimate of $466.97 million. Privia Health Group had a net margin of 0.78% and a return on equity of 2.13%. The company's revenue was up 23.4% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.19 EPS. Privia Health Group has set its FY 2025 guidance at EPS. As a group, equities research analysts forecast that Privia Health Group will post 0.14 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the business. Thrivent Financial for Lutherans grew its stake in Privia Health Group by 1.7% in the 2nd quarter. Thrivent Financial for Lutherans now owns 77,099 shares of the company's stock valued at $1,773,000 after purchasing an additional 1,296 shares during the period. State of Wyoming grew its stake in Privia Health Group by 162.6% in the 2nd quarter. State of Wyoming now owns 32,320 shares of the company's stock valued at $743,000 after purchasing an additional 20,010 shares during the period. Caxton Associates LLP bought a new position in Privia Health Group in the 2nd quarter valued at $329,000. Public Sector Pension Investment Board grew its stake in Privia Health Group by 9.2% in the 2nd quarter. Public Sector Pension Investment Board now owns 357,503 shares of the company's stock valued at $8,223,000 after purchasing an additional 30,256 shares during the period. Finally, Tower Research Capital LLC TRC grew its stake in Privia Health Group by 601.7% in the 2nd quarter. Tower Research Capital LLC TRC now owns 10,547 shares of the company's stock valued at $243,000 after purchasing an additional 9,044 shares during the period. Institutional investors own 94.48% of the company's stock.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.